ALDX

Aldeyra Therapeutics Inc
9.50
0.00 (0.0%)

Aldeyra Therapeutics Inc. (ALDX) Fundamentals

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.
SHARE INFORMATION
Market CapUS$ 556,320,741
Shares Outstanding58,560,078
Float47,622,203
Percent Float81.32%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -1.06
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions246
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months2,925,973
Institutional Holdings Percent80.2%
Institutional Sold Previous 3 Months11,284,271
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months-
Insider Holdings Percent3.9
Insider Sold Previous 3 Months-
Insider Shares Owned2,277,539
TRADING INFO
52 Week HighUS$ 9.68
52 Week LowUS$ 2.36
52 Week High ChangeUS$ 110.18
21 Day Moving AverageUS$ 8.0152
21 Day Extended Moving AverageUS$ 8.1871
50 Day Moving AverageUS$ 7.1154
50 Day Extended Moving AverageUS$ 7.4434
200 Day Moving AverageUS$ 6.0768
200 Day Extended Moving AverageUS$ 6.3439
10 Day Average Volume1,103,264
20 Day Average Volume834,350
30 Day Average Volume727,256
50 Day Average Volume572,488
Alpha0.013467
Beta1.0721
Standard Deviation0.234240
R20.060751
7 Day Price ChangeUS$ 0.44
7 Day Percent Change4.86%
21 Day Price ChangeUS$ 1.60
21 Day Percent Change20.25%
30 Day Price ChangeUS$ 2.74
30 Day Percent Change40.53%
Month to Date Price ChangeUS$ 2.74
Month to Date Percent Change40.53%
Quarter to Date Price ChangeUS$ 2.54
Quarter to Date Percent Change36.49%
180 Day Price ChangeUS$ 4.16
180 Day Percent Change77.9%
200 Day Price ChangeUS$ 2.93
200 Day Percent Change44.6%
Year to Date Price ChangeUS$ 2.54
Year to Date Percent Change36.49%

Aldeyra Therapeutics Inc. (ALDX) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0.00
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book3.70
Total Debt To Equity0.10
Int Coverage-35.60
Current Ratio11.80
Leverage Ratio1.20
Quick Ratio11.60
Long Term Debt To Capital0.09
VALUATION MEASURES
PE Ratio-6.50
Enterprise ValueUS$ 395,175,971
Price to Sales0.00
Price to Free Cash-9.80
PE High Last 5 Years-3.90
Price To Book3.70
Price To Cash Flow0.00
PE Low Last 5 Years-4.50
Price to Tangible Book3.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-29.93
Return on Equity-34.77
Return on Capital-31.13

Aldeyra Therapeutics Inc. (ALDX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorBDO USA, LLP
CEOTodd C. Brady
Emplyoees15
Last AuditUQ
CIK0001341235
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address131 Hartwell Avenue
Suite 320
Lexington, MA 2421
Websitehttps://www.aldeyra.com
Facsimile+1 339 674-6495
Telephone+1 781 761-4904
EmailALDX@investorrelations.com
Your Recent History
NASDAQ
ALDX
Aldeyra Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230331 12:25:42